Prostate Cancer

Symptom experiences of older adults during treatment for metastatic prostate cancer: A qualitative investigation. March 31, 2023

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial. March 31, 2023

Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile. March 31, 2023

Efficacy and safety of apalutamide in patients with metastatic castration-resistant prostate cancer (GENESIS): protocol for a multicentre, open-label, single-arm clinical trial. March 31, 2023

Impact of treatment on elder-relevant physical function and quality of life outcomes in older adults with metastatic castration-resistant prostate cancer. March 31, 2023

Is It Safe to Switch from a Standard Anterior to Retzius-Sparing Approach in Robot-Assisted Radical Prostatectomy? March 30, 2023

Health Care Costs Attributable to Prostate Cancer in British Columbia, Canada: A Population-Based Cohort Study. March 30, 2023

Response to RL-225Ac in prostate cancer: effect of prior treatment with RL-177Lu: a systematic review of the literature. March 30, 2023

Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients. March 30, 2023

Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol. March 30, 2023

Formin-mediated nuclear actin at androgen receptors promotes transcription. March 30, 2023

Novel Paired Normal Prostate and Prostate Cancer Model Cell Systems Derived from African American Patients. March 30, 2023

Drug-gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition. March 30, 2023

Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers. March 29, 2023

Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis. March 29, 2023

Intrafraction motion during CyberKnife® prostate SBRT: impact of imaging frequency and patient factors. March 29, 2023

Prognostic significance of PI-RADS 5 lesions in patients treated by radical prostatectomy. March 29, 2023

Optimizing detection of clinically significant prostate cancer through nomograms incorporating mri, clinical features, and advanced serum biomarkers in biopsy naïve men. March 29, 2023

Race-dependent association of clinical trial participation with improved outcomes for high-risk prostate cancer patients treated in the modern era. March 28, 2023

Predicting prostate cancer in men with PSA levels of 4-10 ng/mL: MRI-based radiomics can help junior radiologists improve the diagnostic performance. March 28, 2023

Page 1 of 1290